Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
IMMUNE PHARMACEUTICALS INC (0001208261) Financials & SEC Data · SECfinAPI
Company
IMMUNE PHARMACEUTICALS INC (0001208261)
Standardized SEC financial data for IMMUNE PHARMACEUTICALS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001208261 · Pharmaceutical Preparations.
Return on equity
-130.0%
ROIC
-77.4%
Free cash flow
-$11.6M
Debt / equity
0.39×
Current ratio
0.76×
Ratios for fiscal year 2017, standardized from SEC filings.
Income statement
USD
FY2016
FY2017
Revenue
$0
$0
R&D expense
$8.3M
$5.5M
SG&A expense
$6.4M
$6.6M
Operating income
-$27.3M
-$12.1M
EBITDA
-$26.9M
-$11.5M
Interest expense
$1.6M
$3.7M
Pretax income
-$37.5M
-$19.9M
Income tax
$4.9M
Standardized from IMMUNE PHARMACEUTICALS INC's SEC filings — per-share figures split-adjusted. Full history via the API.